(Q44881825)

7 December 2017

title

Cytokine mRNA expression in patients with multiple sclerosis and fatigue (English)

1 reference

7 December 2017

0 references

0 references

5

Klaus V Toyka

1 reference

7 December 2017

Peter Flachenecker

1

1 reference

7 December 2017

Irene Bihler

2

1 reference

7 December 2017

F Weber

3

1 reference

7 December 2017

M Gottschalk

4

1 reference

7 December 2017

Peter Rieckmann

6

1 reference

7 December 2017

language of work or name

1 reference

1 April 2004

1 reference

Multiple Sclerosis Journal

7 December 2017

published in

1 reference

7 December 2017

volume

10

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

165-169

1 reference

Symptomatic therapy for underrecognized manifestations of multiple sclerosis

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

An electrophysiological study of the mechanism of fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Fatigue and proinflammatory cytokine activity in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

The role of cytokines in cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Physiopathology and treatment of fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Immunological indicators of disease activity and prognosis in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Induction of apoptosis in mature T cells by tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Fatigue is not associated with raised inflammatory markers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS991OA

10.1191/1352458504MS991OA

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference